<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38503498</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID-19 Survivors: A 2-Year Cohort Study.</ArticleTitle><Pagination><StartPage>e13263</StartPage><MedlinePgn>e13263</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13263</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.13263</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Abnormal changes of monocytes have been observed in acute COVID-19, whereas associations of monocyte count with long COVID were not sufficiently elucidated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cohort study was conducted among COVID-19 survivors discharged from hospital. The primary outcomes were core symptoms of long COVID, distance walked in 6&#x2009;min, and lung function, and the secondary outcomes were health-related quality of life and healthcare use after discharge. Latent variable mixture modeling was used to classify individuals into groups with similar trajectory of monocyte count from discharge to 2-year after symptom onset. Multivariable adjusted generalized linear regression models and logistic regression models were used to estimate the associations of monocyte count trajectories and monocyte count at discharge with outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 1389 study participants were included in this study. Two monocyte count trajectories including high to normal high and normal trajectory were identified. After multivariable adjustment, participants in high to normal high trajectory group had an odds ratio (OR) of 2.52 (95% CI, 1.44-4.42) for smell disorder, 2.27 (1.27-4.04) for 6-min walking distance less than lower limit of normal range, 2.45 (1.08-5.57) for total lung capacity (TLC)&#x2009;&lt;&#x2009;80% of predicted, 3.37 (1.16-9.76) for personal care problem, and 1.70 (1.12-2.58) for rehospitalization after discharge at 2-year follow-up compared with those in normal trajectory group. Monocyte count at discharge showed similar results, which was associated with smell disorder, TLC&#x2009;&lt;&#x2009;80% of predicted, diffusion impairment, and rehospitalization.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Monocyte count may serve as an easily accessible marker for long-term management of people recovering from COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xiaoying</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2712-9870</Identifier><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research and Data Management, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Lixue</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yeming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Hubei Provincial Clinical Research Center for Infectious Diseases, Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Center for Respiratory Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Respiratory Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82041011</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82200114</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2018-I2M-1-003</GrantID><Agency>Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences</Agency><Country/></Grant><Grant><GrantID>2020-I2M-CoV19-005</GrantID><Agency>Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences</Agency><Country/></Grant><Grant><GrantID>2018YFC1200102</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>ZYYCXTD-D-202208</GrantID><Agency>National Administration of Traditional Chinese Medicine</Agency><Country/></Grant><Grant><GrantID>2020ZX09201001</GrantID><Agency>Major Projects of National Science and Technology on New Drug Creation and Development of Pulmonary Tuberculosis</Agency><Country/></Grant><Grant><Agency>China Evergrande Group</Agency><Country/></Grant><Grant><Agency>Jack Ma Foundation</Agency><Country/></Grant><Grant><Agency>Sino Biopharmaceutical</Agency><Country/></Grant><Grant><Agency>Ping An Insurance (Group)</Agency><Country/></Grant><Grant><Agency>New Sunshine Charity Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">6-min walking distance</Keyword><Keyword MajorTopicYN="N">healthcare use</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lung function</Keyword><Keyword MajorTopicYN="N">monocyte</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38503498</ArticleId><ArticleId IdType="pmc">PMC10950557</ArticleId><ArticleId IdType="doi">10.1111/irv.13263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van de Veerdonk F. L., Giamarellos&#x2010;Bourboulis E., Pickkers P., et&#xa0;al., &#x201c;A Guide to Immunotherapy for COVID&#x2010;19,&#x201d; Nature Medicine 28, no. 1 (2022): 39&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">35064248</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C. A., Sallusto F., and Iwasaki A., &#x201c;The Immunology and Immunopathology of COVID&#x2010;19,&#x201d; Science 375, no. 6585 (2022): 1122&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M. and Martin J. C., &#x201c;Pathological Inflammation in Patients with COVID&#x2010;19: A Key Role for Monocytes and Macrophages,&#x201d; Nature Reviews. Immunology 20, no. 6 (2020): 355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos&#x2010;Bourboulis E. J., Netea M. G., Rovina N., et&#xa0;al., &#x201c;Complex Immune Dysregulation in COVID&#x2010;19 Patients With Severe Respiratory Failure,&#x201d; Cell Host &amp; Microbe 27, no. 6 (2020): 992&#x2013;1000.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter L. O., Cardoso C. C., Santos&#x2010;Pirath I. M., et&#xa0;al., &#x201c;The Relationship Between Peripheral Immune Response and Disease Severity in SARS&#x2010;CoV&#x2010;2&#x2010;Infected Subjects: A Cross&#x2010;Sectional Study,&#x201d; Immunology 165, no. 4 (2022): 481&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111570</ArticleId><ArticleId IdType="pubmed">35146763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao C., Bora S. A., Parimon T., et&#xa0;al., &#x201c;Cell&#x2010;Type&#x2010;Specific Immune Dysregulation in Severely Ill COVID&#x2010;19 Patients,&#x201d; Cell Reports 34, no. 13 (2021): 108943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009498</ArticleId><ArticleId IdType="pubmed">33789116</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeke L., Van Mol P., Van Herck Y., et&#xa0;al., &#x201c;Monocyte&#x2010;Driven Atypical Cytokine Storm and Aberrant Neutrophil Activation as Key Mediators of COVID&#x2010;19 Disease Severity,&#x201d; Nature Communications 12, no. 1 (2021): 4117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257697</ArticleId><ArticleId IdType="pubmed">34226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A., Chapuis N., Dunsmore G., et&#xa0;al., &#x201c;Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe From Mild COVID&#x2010;19,&#x201d; Cell 182, no. 6 (2020): 1401&#x2013;1418.e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M., Liu Y., Yuan J., et&#xa0;al., &#x201c;Single&#x2010;Cell Landscape of Bronchoalveolar Immune Cells in Patients With COVID&#x2010;19,&#x201d; Nature Medicine 26, no. 6 (2020): 842&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte&#x2010;Schrepping J., Reusch N., Paclik D., et&#xa0;al., &#x201c;Severe COVID&#x2010;19 Is Marked by a Dysregulated Myeloid Cell Compartment,&#x201d; Cell 182, no. 6 (2020): 1419&#x2013;1440.e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F. O., Combes T. W., Orsenigo F., and Gordon S., &#x201c;Monocyte Activation in Systemic Covid&#x2010;19 Infection: Assay and Rationale,&#x201d; eBioMedicine 59 (2020): 102964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456455</ArticleId><ArticleId IdType="pubmed">32861199</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J. B., Murthy S., Marshall J. C., Relan P., and Diaz J. V., &#x201c;A Clinical Case Definition of Post&#x2010;COVID&#x2010;19 Condition by a Delphi Consensus,&#x201d; The Lancet Infectious Diseases 22, no. 4 (2022): e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott M. K. D., Quinn K., Li Q., et&#xa0;al., &#x201c;Increased Monocyte Count as a Cellular Biomarker for Poor Outcomes in Fibrotic Diseases: A Retrospective, Multicentre Cohort Study,&#x201d; The Lancet Respiratory Medicine 7, no. 6 (2019): 497&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6529612</ArticleId><ArticleId IdType="pubmed">30935881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuter M., Lee J. S., Tzouvelekis A., et&#xa0;al., &#x201c;Monocyte Count as a Prognostic Biomarker in Patients With Idiopathic Pulmonary Fibrosis,&#x201d; American Journal of Respiratory and Critical Care Medicine 204, no. 1 (2021): 74&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437112</ArticleId><ArticleId IdType="pubmed">33434107</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et&#xa0;al., &#x201c;6&#x2010;Month Consequences of COVID&#x2010;19 in Patients Discharged From Hospital: A Cohort Study,&#x201d; Lancet 401, no. 10393 (2023): e21&#x2013;e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., et&#xa0;al., &#x201c;1&#x2010;Year Outcomes in Hospital Survivors with COVID&#x2010;19: A Longitudinal Cohort Study,&#x201d; Lancet 398, no. 10302 (2021): 747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., et&#xa0;al., &#x201c;Health Outcomes in People 2 Years After Surviving Hospitalisation with COVID&#x2010;19: A Longitudinal Cohort Study,&#x201d; The Lancet Respiratory Medicine 10, no. 9 (2022): 863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks&#x2010;Manov N., et&#xa0;al., &#x201c;Long Covid Outcomes at One Year After Mild SARS&#x2010;CoV&#x2010;2 Infection: Nationwide Cohort Study,&#x201d; BMJ 380 (2023): e072529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A. V., van Zon S. K., Olde Hartman T. C., and Rosmalen J. G., &#x201c;Persistence of Somatic Symptoms After COVID&#x2010;19 in the Netherlands: An Observational Cohort Study,&#x201d; The Lancet 400, no. 10350 (2022): 452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampitsakos T., Torrisi S., Antoniou K., et&#xa0;al., &#x201c;Increased Monocyte Count and Red Cell Distribution Width as Prognostic Biomarkers in Patients With Idiopathic Pulmonary Fibrosis,&#x201d; Respiratory Research 22, no. 1 (2021): 140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8097815</ArticleId><ArticleId IdType="pubmed">33952261</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., and Iwasaki A., &#x201c;Unexplained Post&#x2010;Acute Infection Syndromes,&#x201d; Nature Medicine 28, no. 5 (2022): 911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamanickam A., Kumar N. P., Pandiarajan A. N., et&#xa0;al., &#x201c;Dynamic Alterations in Monocyte Numbers, Subset Frequencies and Activation Markers in Acute and Convalescent COVID&#x2010;19 Individuals,&#x201d; Scientific Reports 11, no. 1 (2021): 20254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511073</ArticleId><ArticleId IdType="pubmed">34642411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B., Boustani K., Ogger P. P., et&#xa0;al., &#x201c;Immuno&#x2010;Proteomic Profiling Reveals Aberrant Immune Cell Regulation in the Airways of Individuals With Ongoing Post&#x2010;COVID&#x2010;19 Respiratory Disease,&#x201d; Immunity 55, no. 3 (2022): 542&#x2013;556.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Misharin A. V., Morales&#x2010;Nebreda L., Reyfman P. A., et&#xa0;al., &#x201c;Monocyte&#x2010;Derived Alveolar Macrophages Drive Lung Fibrosis and Persist in the Lung Over the Life Span,&#x201d; The Journal of Experimental Medicine 214, no. 8 (2017): 2387&#x2013;2404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5551573</ArticleId><ArticleId IdType="pubmed">28694385</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi N., Watanabe S., Verma R., et&#xa0;al., &#x201c;A Spatially Restricted Fibrotic Niche in Pulmonary Fibrosis Is Sustained by M&#x2010;CSF/M&#x2010;CSFR Signalling in Monocyte&#x2010;Derived Alveolar Macrophages,&#x201d; The European Respiratory Journal 55, no. 1 (2020): 1900646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962769</ArticleId><ArticleId IdType="pubmed">31601718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylvaganam R. J., Bailey J. I., Sznajder J. I., Sala M. A., and Northwestern Comprehensive CCC , &#x201c;Recovering From a Pandemic: Pulmonary Fibrosis After SARS&#x2010;CoV&#x2010;2 Infection,&#x201d; European Respiratory Review 30, no. 162 (2021): 210194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674935</ArticleId><ArticleId IdType="pubmed">34911696</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh A. K. Y., Jo H. E., Chambers D. C., et&#xa0;al., &#x201c;Blood Monocyte Counts as a Potential Prognostic Marker for Idiopathic Pulmonary Fibrosis: Analysis From the Australian IPF Registry,&#x201d; The European Respiratory Journal 55, no. 4 (2020): 1901855.</Citation><ArticleIdList><ArticleId IdType="pubmed">31949112</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S. R., Ramelli S. C., Grazioli A., et&#xa0;al., &#x201c;SARS&#x2010;CoV&#x2010;2 Infection and Persistence in the Human Body and Brain at Autopsy,&#x201d; Nature 612, no. 7941 (2022): 758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D., Lim J. C. T., Fernaindez S. B., et&#xa0;al., &#x201c;Case Report: Persistence of Residual Antigen and RNA of the SARS&#x2010;CoV&#x2010;2 Virus in Tissues of Two Patients with Long COVID,&#x201d; Frontiers in Immunology 13 (2022): 939989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>